Luise Goerlitz

发表

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

A. Carnahan, V. Enouf, M. Hooiveld, 2024, Influenza and Other Respiratory Viruses.

Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe

M. Hooiveld, A. Larrauri, E. Kissling, 2024, Vaccine.

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

M. Hooiveld, E. Kissling, B. Oroszi, 2024, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.